Kotsougiani Dimitra, Hundepool Caroline A, Bulstra Liselotte F, Friedrich Patricia F, Shin Alexander Y, Bishop Allen T
Microvascular Research Laboratory, Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
Department of Hand, Plastic and Reconstructive Surgery, Burn Center, BG Trauma Center Ludwigshafen, Department of Plastic Surgery, University of Heidelberg, Heidelberg, Germany.
Microsurgery. 2019 Feb;39(2):160-166. doi: 10.1002/micr.30310. Epub 2018 Mar 5.
In prior small animal studies, we maintained vascularized bone allotransplant viability without long-term immunotherapy. Instead, an autogenous neoangiogenic circulation is created from implanted vessels, sufficient to maintain bone viability with only 2 weeks immunosupression. Blood flow is maintained despite rejection of the allogeneic vascular pedicle thereafter. We have previously described a large animal (swine) pre-clinical model, reconstructing tibial defects with vascularized tibial allotransplants. In this manuscript, autologous angiogenesis is evaluated in this model and correlated with bone viability.
Allogeneic tibial segments were transplanted across a major swine leukocyte antigen mismatch. Microvascular repair of the bone VCA pedicle was combined with intraosseous implantation of an autogenous arteriovenous (AV) bundle. The bundle was ligated in group 1 (n = 4), and allowed to perfuse in group 2 (n = 4). Three-drug immunotherapy was given for 2 weeks. At 16 weeks micro-CT angiography quantified neoangiogenic vessel volume. Bone viability, rejection grade, and bone healing were analyzed.
A substantial neoangiogenic circulation developed from the implanted AV-bundle in group 2, with vessel density superior to ligated AV-bundle controls (0.11 ± 0.05 vs. 0.01 ± 0.01, P = .029). Bone allotransplant viability was also significantly enhanced by neoangiogenesis (78.7 ± 4.4% vs. 27.7 ± 5.8%, P = .028) with higher bone healing scores (21.4 ± 2.9 vs. 12.5 ± 3.7, P = .029). Ligated control tibias demonstrated disorganized bone morphology and higher local inflammation (P = .143).
Implantation of autogenous AV bundles into vascularized bone allotransplants resulted in the rapid formation of a neoangiogenic autogenous blood supply in a swine tibia model that maintained bone viability, improved bone healing, and minimized rejection.
在先前的小动物研究中,我们在没有长期免疫治疗的情况下维持了血管化同种异体骨移植的活力。相反,通过植入血管形成了自体新生血管循环,仅需2周免疫抑制就足以维持骨活力。尽管同种异体血管蒂随后发生排斥反应,但仍维持了血流。我们之前描述了一种大型动物(猪)临床前模型,用血管化胫骨同种异体移植重建胫骨缺损。在本手稿中,在该模型中评估了自体血管生成并将其与骨活力相关联。
同种异体胫骨段跨越主要猪白细胞抗原错配进行移植。骨血管蒂吻合术的微血管修复与自体动静脉(AV)束的骨内植入相结合。第1组(n = 4)结扎束,第2组(n = 4)允许束灌注。给予三周药物免疫治疗。在16周时,微型计算机断层扫描血管造影术对新生血管体积进行量化。分析骨活力、排斥等级和骨愈合情况。
第2组中,植入的AV束形成了大量的新生血管循环,血管密度优于结扎AV束的对照组(0.11±0.05对0.01±0.01,P = 0.029)。新生血管生成也显著提高了同种异体骨移植的活力(78.7±4.4%对27.7±5.8%,P = 0.028),骨愈合评分更高(21.4±2.9对12.5±3.7,P = 0.029)。结扎的对照胫骨显示出骨形态紊乱和更高的局部炎症(P = 0.143)。
在猪胫骨模型中,将自体AV束植入血管化同种异体骨移植中可快速形成自体新生血管血供,维持骨活力,改善骨愈合,并使排斥反应最小化。